Literature DB >> 10445578

Treatment of chronic hepatitis C with amantadine.

I F Hubert, F Lunel, J F Cadranel, F Oberti, P Calès.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10445578     DOI： 10.1111/j.1572-0241.1999.2316b.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

1.  Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine.

Authors:  Rudolf E Stauber; Harald Hofer; Franz Hackl; Kurt Schütze; Christian Datz; Karin Hegenbarth; Wolfgang Jessner; Petra Steindl-Munda; Ferenci Peter
Journal:  Wien Klin Wochenschr       Date:  2004-08-31       Impact factor: 1.704

2.  Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naïve patients with chronic hepatitis C.

Authors:  P J Thuluvath; A Maheshwari; J Mehdi; K D Fairbanks; L L-W Wu; L G Gelrud; M J Ryan; F A Anania; I F Lobis; M Black
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 3.  Amantadine for chronic hepatitis c: a magic bullet or yet another dead duck?

Authors:  A Craxi; O Lo Lacono
Journal:  J Hepatol       Date:  2001-10       Impact factor: 25.083
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.